D. Zembower

发表

Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex.

Y. Pommier, A. Burgin, L. Stewart, 2005, Journal of medicinal chemistry.

Corrections to Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography

M. Gurney, O. Magnusson, A. Burgin, 2010, Journal of Medicinal Chemistry.

Discovery of Leukotriene A4 Hydrolase Inhibitors Using Metabolomics Biased Fragment Crystallography†

Brian Pease, Lance J. Stewart, Alex B. Burgin, 2009, Journal of medicinal chemistry.

Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis.

M. Krohn, M. Gurney, L. Stewart, 2010, Journal of medicinal chemistry.

In vitro anti-human immunodeficiency virus (HIV) activity of the chromanone derivative, 12-oxocalanolide A, a novel NNRTI.

D. Zembower, R. Buckheit, A. Khilevich, 1998, Bioorganic & medicinal chemistry letters.

Development of a Scalable Process for DG-041, a Potent EP3 Receptor Antagonist, via Tandem Heck Reactions

D. Zembower, Jasbir Singh, L. Enache, 2007 .

Peptide boronic acids. Versatile synthetic ligands for affinity chromatography of serine proteinases.

M. Wick, M. Ames, D. Zembower, 2009, International journal of peptide and protein research.

Structure-activity relationship studies leading to the identification of (2E)-3-[l-[(2,4-dichlorophenyl)methyl]-5-fluoro-3-methyl-lH-indol-7-yl]-N-[(4,5-dichloro-2-thienyl)sulfonyl]-2-propenamide (DG-041), a potent and selective prostanoid EP3 receptor antagonist, as a novel antiplatelet agent that

M. Gurney, D. Zembower, A. Kiselyov, 2010, Journal of medicinal chemistry.

Diethyldithiocarbamate S-methylation: evidence for catalysis by human liver thiol methyltransferase and thiopurine methyltransferase.

R. Weinshilboum, T. Glauser, D. Zembower, 1993, The Journal of pharmacology and experimental therapeutics.

Synthesis of (+)-calanolide A, an anti-HIV agent, Via enzyme-catalyzed resolution of the aldol products

Wei Chen, D. Zembower, S. Liao, 1996 .

Structural analogues of the calanolide anti-HIV agents. Modification of the trans-10,11-dimethyldihydropyran-12-ol ring (ring C).

D. Zembower, R. Buckheit, S. Liao, 1997, Journal of medicinal chemistry.

Structural analogues of the calanolide anti-HIV agents. Modification of the trans-10,11-dimethyldihydropyran-12-ol ring (ring C).

D. Zembower, R. Buckheit, S. Liao, 1997, Journal of medicinal chemistry.

Total Synthesis of Robustaflavone, a Potential Anti-Hepatitis B Agent.

Heping Zhang, D. Zembower, 1999 .

Total Synthesis of Robustaflavone, a Potential Anti-Hepatitis B Agent

Heping Zhang, D. Zembower, 1998 .

Robustaflavone, a potential non-nucleoside anti-hepatitis B agent.

D. Zembower, B. Korba, Y. M. Lin, 1998, Antiviral research.

Robustaflavone, a naturally occurring biflavanoid, is a potent non-nucleoside inhibitor of hepatitis B virus replication in vitro

D. Zembower, B. Korba, M. Flavin, 1997 .

Synthesis and structural assignment of two major metabolites of the LTA4H inhibitor DG-051.

D. Zembower, A. Kiselyov, Jasbir Singh, 2009, Bioorganic & medicinal chemistry letters.

Structural analogues of the michellamine anti-HIV agents. Importance of the tetrahydroisoquinoline rings for biological activity

Heping Zhang, D. Zembower, Zhidong Chen, 1997 .

Indolocarbazole poisons of human topoisomerase I: regioisomeric analogues of ED-110.

M. Ames, D. Zembower, M. Kuffel, 1999, Bioorganic & medicinal chemistry letters.

Synthesis of 5,8-dimethoxy-3-hydroxy-4-quinolone, a reported inhibitor of HIV RT, and evidence the original proposed structure was incorrect.

D. Zembower, S. Aytes, 1999, Bioorganic & medicinal chemistry letters.

Efficient reversed-phase purification of a hydrophobic reaction product following Mitsunobu-mediated glycosylation.

D. Zembower, Kevin M. Schilling, Yongping Xie, 2002, Journal of chromatography. A.

Automated Process Research. An Example of Accelerated Optimization of the Friedel−Crafts Acylation Reaction, a Key Step for the Synthesis of Anti-HIV (+)-Calanolide A

D. Zembower, M. Flavin, P. Sen, 2000 .

Antagonists of the EP3 receptor for prostaglandin E2 are novel antiplatelet agents that do not prolong bleeding.

K. Stefánsson, M. Gurney, O. Magnusson, 2009, ACS chemical biology.

Enantiospecific syntheses of alpha-(fluoromethyl)tryptophan analogues: interactions with tryptophan hydroxylase and aromatic L-amino acid decarboxylase.

M. Ames, D. Zembower, J. Gilbert, 1993, Journal of Medicinal Chemistry.